State AGs urge Pennsylvania court to select dermatology lawsuit as bellwether

Alex Wilts

02 March 2021

Shutterstock/Aleksandra Gigowska

A Connecticut-led group of states has argued that its lawsuit alleging collusion in markets for dermatological products should be the first to go to trial in sprawling multidistrict litigation accusing generic drug manufacturers of price-fixing and market allocation.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Alex Wilts

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Gym class heroes: The Tipline for 30 June 2022
The Federal Trade Commission’s Democrats aren’t fans of PE. The agency’s majority sees private equity as M&A’s version of high school gym class, but instead of challenging students with shaky pushups and sweaty pullups, it's swallowing up small businesses with stealthy rollups and leveraged buyouts. For the second time this month, the commission is trumpeting the fact that it required conditional approval for a PE firm’s proposed merger – even if those assets are …
Walmart’s consumer protection paradox: The Tipline for 29 June 2022
The fix is in, preliminarily: The Tipline for 28 June 2022

State AGs urge Pennsylvania court to select dermatology lawsuit as bellwether

Subscribe to Global Competition Review

Subscribe and start reading now

Already have access? Login below

Related Topics

Alex Wilts